Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA manufacturing GMP documents

Executive Summary

FDA plans to issue final quality systems guidance by summer, FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb says March 14 at the International GMP Conference in Athens, Ga. The September 2004 draft guidance, which was part of FDA's final report on its Pharmaceutical cGMP Initiative for the 21st Century, calls for regular analysis of trends in batch quality (1"The Pink Sheet" Oct. 4, 2004, p. 20). FDA also plans to complete a report summarizing "the work of our risk management work group, which was charged with identifying continuous improvements in the risk model for prioritizing sites for manufacturing inspections," Gottlieb adds...

You may also be interested in...



FDA Quality Systems Guidance Suggests “Trending” For Batch Testing

A quality systems approach to manufacturing should include continual monitoring and analysis of trends in batch quality, FDA's quality systems draft guidance states

COVID-19 Lessons: Experts Predict Shift Toward Intermittent Hemodialysis In ICUs

The pandemic may accelerate a move toward versatile, single-solution renal replacement therapy in intensive care.

COVID-19: FDA Schedules 4 More Virtual Town Halls Through October

The US agency has announced another month of webinars aimed at labs and manufacturers that are developing – or have developed – diagnostic tests for the novel coronavirus.

UsernamePublicRestriction

Register

MT142539

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel